PROCEPT BioRobotics Corporation (PRCT) Tops Q2 EPS by 1c

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q2 EPS of ($0.56), $0.01 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $33.1 million versus the consensus estimate of $30.31 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.

You May Also Be Interested In

• Important Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Insulet Corporation (NASDAQ: PODD); Power Solutions International, Inc. (NASDAQ: PSIX); and PROCEPT BioRobotics Corporation (
• Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance
• Stantec (STN) Tops Q2 EPS by 47c